WuXi AppTec’s Lab Testing Division (LTD), a late-and commercial-stage analytical and stability testing facility in Shanghai, has passed an FDA inspection for GMP compliance.

The inspection evaluated WuXi LTD’s quality system during a four-day inspection, with focus on data integrity and compliance across its GMP analytical and stability testing facilities. The inspection confirmed WuXi’s adherence to FDA’s GMP guidance.

“FDA expects the highest quality and data integrity, and we are proud to receive a very positive feedback, “said Dr. Ge Li, chairman and chief executive officer of WuXi AppTec, “We will continue to uphold the highest quality standards and provide best-in-class R&D services for our customers worldwide.”